PHARMACOKINETICS OF ANTIBIOTICS IN SHALLOW AND DEEP COMPARTMENTS

被引:30
作者
BARZA, M
机构
[1] Division of Geographic Medicine and Infectious Diseases, New England Medical Center, Boston, MA, 02111
关键词
D O I
10.1093/jac/31.suppl_D.17
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This paper reviews the influence of the type of capillary bed, type of compartment, and the presence of active transport systems, on the phannacokinetics of antimicrobial agents in tissues and fluids of the body. In the absence of active transport or local degradation, the mean concentration or ‘area under the curve’ of free (unbound) drug in ordinary extravascular sites over the dosing interval at equilibrium is equal to that in the serum. Because the latter is easily measured, there should be no need to measure tissue concentrations except in unusual circumstances. Among the factors that will alter the relationship described above are active transport, pH partition, and bulk flow. Antibiotics such as the macrolides, lincosa-mines and quinolones may accumulate in high concentrations in cells containing lysosomes. There is some evidence that the intracellular sites may serve as a reservoir from which these drugs may later be released into tissue fluids, a phenomenon not taken into account in the relationships described above. Although knowledge of the in-vitro activity and local concentrations of antibiotics is of use in predicting therapeutic activity, many factors which are difficult to quantify in a given instance make precise correlations impossible. The inability of antibiotics alone to sterilize abscesses is probably not due to a problem in antibiotic penetration but to insusceptibility of the organisms and inefficacy of the phagocytes in an abscess. Similar processes operate to reduce the efficacy of antibiotics when treatment is delayed. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 42 条
[11]   SIGNIFICANCE OF TISSUE-LEVELS FOR PREDICTION OF ANTIBIOTIC EFFICACY AND DETERMINATION OF DOSAGE [J].
CARBON, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (07) :510-516
[12]   CELLULAR UPTAKE AND SUBCELLULAR-DISTRIBUTION OF ROXITHROMYCIN AND ERYTHROMYCIN IN PHAGOCYTIC-CELLS [J].
CARLIER, MB ;
ZENEBERGH, A ;
TULKENS, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :47-56
[13]  
Cars O, 1990, Scand J Infect Dis Suppl, V74, P23
[14]  
CRAIG W, 1992, 32ND INT C ANT AG CH
[15]   DOSE-RESPONSE OF EXPERIMENTAL PSEUDOMONAS ENDOPHTHALMITIS TO CIPROFLOXACIN, GENTAMICIN, AND IMIPENEM - EVIDENCE FOR RESISTANCE TO LATE TREATMENT OF INFECTIONS [J].
DAVEY, PG ;
BARZA, M ;
STUART, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (03) :518-523
[16]   LYSOSOMOTROPIC AGENTS [J].
DEDUVE, C ;
DEBARSY, T ;
POOLE, B ;
TROUET, A ;
TULKENS, P ;
VANHOOF, F .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (18) :2495-+
[17]   CONTINUOUS VS DISCONTINUOUS THERAPY WITH PENICILLIN - THE EFFECT OF THE INTERVAL BETWEEN INJECTIONS ON THERAPEUTIC EFFICACY [J].
EAGLE, H ;
FLEISCHMAN, R ;
LEVY, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1953, 248 (12) :481-488
[19]  
FERNANDES PB, 1986, ANTIMICROBIAL AGENTS, V30, P1865
[20]   CORRELATION OF THE EXTRAVASCULAR PHARMACOKINETICS OF AZITHROMYCIN WITH INVIVO EFFICACY IN MODELS OF LOCALIZED INFECTION [J].
GIRARD, AE ;
GIRARD, D ;
RETSEMA, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :61-71